{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:00:15Z","timestamp":1790290815949,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173844"],"award-info":[{"award-number":["82173844"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Proced Online"],"DOI":"10.1186\/s12575-026-00348-y","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:24:56Z","timestamp":1783052696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethacrynic Oxadiazole 6u Induces Apoptosis by Targeting mTOR\/c-Flip Axis and Noxa in Lymphoma Cells"],"prefix":"10.1186","volume":"28","author":[{"given":"Yafei","family":"Kuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuoyan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuomin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Waxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkui","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"348_CR1","doi-asserted-by":"crossref","unstructured":"Yu L, Lee H, Rho SB, Park MK, Lee CH. Ethacrynic acid: a promising candidate for drug repurposing as an anticancer agent. Int J Mol Sci. 2023;24:6712.","DOI":"10.3390\/ijms24076712"},{"key":"348_CR2","doi-asserted-by":"publisher","first-page":"7856","DOI":"10.1158\/0008-5472.CAN-07-0151","volume":"67","author":"R Wang","year":"2007","unstructured":"Wang R, Li C, Song D, Zhao G, Zhao L, Jing Y. Ethacrynic acid butyl-ester induces apoptosis in leukemia cells through a hydrogen peroxide mediated pathway independent of glutathione S-transferase P1\u20131 inhibition. Cancer Res. 2007;67:7856\u201364.","journal-title":"Cancer Res"},{"key":"348_CR3","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1016\/j.bmc.2005.03.046","volume":"13","author":"G Zhao","year":"2005","unstructured":"Zhao G, Yu T, Wang R, Wang X, Jing Y. Synthesis and structure-activity relationship of ethacrynic acid analogues on glutathione-s-transferase P1\u20131 activity inhibition. Bioorg Med Chem. 2005;13:4056\u201362.","journal-title":"Bioorg Med Chem"},{"key":"348_CR4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1021\/jm9011565","volume":"53","author":"X Yang","year":"2010","unstructured":"Yang X, Liu G, Li H, Zhang Y, Song D, Li C, et al. Novel oxadiazole analogues derived from ethacrynic acid: design, synthesis, and structure-activity relationships in inhibiting the activity of glutathione S-transferase P1\u20131 and cancer cell proliferation. J Med Chem. 2010;53:1015\u201322.","journal-title":"J Med Chem"},{"key":"348_CR5","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.bmc.2012.02.011","volume":"20","author":"T Li","year":"2012","unstructured":"Li T, Liu G, Li H, Yang X, Jing Y, Zhao G. The synthesis of ethacrynic acid thiazole derivatives as glutathione S-transferase pi inhibitors. Bioorg Med Chem. 2012;20:2316\u201322.","journal-title":"Bioorg Med Chem"},{"key":"348_CR6","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1158\/1078-0432.CCR-12-0770","volume":"18","author":"R Wang","year":"2012","unstructured":"Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, et al. Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p 1\u20131. Clin Cancer Res. 2012;18:6690\u2013701.","journal-title":"Clin Cancer Res"},{"key":"348_CR7","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1158\/1535-7163.MCT-12-1224","volume":"12","author":"G Liu","year":"2013","unstructured":"Liu G, Wang R, Wang Y, Li P, Zhao G, Zhao L, et al. Ethacrynic acid oxadiazole analogs induce apoptosis in malignant hematologic cells through downregulation of Mcl-1 and c-FLIP, which was attenuated by GSTP1-1. Mol Cancer Ther. 2013;12:1837\u201347.","journal-title":"Mol Cancer Ther"},{"key":"348_CR8","first-page":"191072","volume":"2014","author":"S Bala","year":"2014","unstructured":"Bala S, Sharma N, Kajal A, Kamboj S, Saini V. Mannich bases: an important pharmacophore in present scenario. Int J Med Chem. 2014;2014:191072.","journal-title":"Int J Med Chem"},{"key":"348_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.59556\/japi.72.0669","volume":"72","author":"J Pal","year":"2024","unstructured":"Pal J, Tiwaskar M, Garg S, Khare AN, Patil S, Bhutani J, et al. Loop diuretics: an overview of its history and evolution. J Assoc Physicians India. 2024;72:11\u20133.","journal-title":"J Assoc Physicians India"},{"key":"348_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","volume":"12","author":"H Hua","year":"2019","unstructured":"Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y. Targeting mTOR for cancer therapy. J Hematol Oncol. 2019;12:71.","journal-title":"J Hematol Oncol"},{"key":"348_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/CAD.0000000000000116","volume":"25","author":"T Zhang","year":"2014","unstructured":"Zhang T, Wang X, He D, Jin X, Guo P. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR\/S6K1-mediated downregulation of c-FLIP. Anticancer Drugs. 2014;25:887\u201397.","journal-title":"Anticancer Drugs"},{"key":"348_CR12","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1158\/0008-5472.CAN-12-3710","volume":"73","author":"L Zhao","year":"2013","unstructured":"Zhao L, Yue P, Khuri FR, Sun SY. mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis. Cancer Res. 2013;73:1946\u201357.","journal-title":"Cancer Res"},{"key":"348_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1042\/BST0390456","volume":"39","author":"G Marshall","year":"2011","unstructured":"Marshall G, Howard Z, Dry J, Fenton S, Heathcote D, Gray N, et al. Benefits of mTOR kinase targeting in oncology: pre-clinical evidence with AZD8055. Biochem Soc Trans. 2011;39:456\u20139.","journal-title":"Biochem Soc Trans"},{"key":"348_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1586\/17474086.2015.1026321","volume":"8","author":"J Huang","year":"2015","unstructured":"Huang J, Fairbrother W, Reed JC. Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies. Expert Rev Hematol. 2015;8:283\u201397.","journal-title":"Expert Rev Hematol"},{"key":"348_CR15","doi-asserted-by":"crossref","unstructured":"Klanova M, Klener P. BCL-2 proteins in pathogenesis and therapy of B-cell non-Hodgkin lymphomas. Cancers (Basel). 2020;12.","DOI":"10.3390\/cancers12040938"},{"key":"348_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17:395\u2013417.","journal-title":"Nat Rev Clin Oncol"},{"key":"348_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.14740\/jh2092","volume":"14","author":"A Hanbali","year":"2025","unstructured":"Hanbali A, Kotb A, Saleh M. B-cell lymphoma 2 inhibition in acute lymphoblastic leukemia: mechanisms, resistance, and emerging combinations with Venetoclax. J Hematol. 2025;14:193\u2013201.","journal-title":"J Hematol"},{"key":"348_CR18","doi-asserted-by":"publisher","first-page":"1226289","DOI":"10.3389\/fonc.2023.1226289","volume":"13","author":"SI Tantawy","year":"2023","unstructured":"Tantawy SI, Timofeeva N, Sarkar A, Gandhi V. Targeting MCL-1 protein to treat cancer: opportunities and challenges. Front Oncol. 2023;13:1226289.","journal-title":"Front Oncol"},{"key":"348_CR19","first-page":"6059","volume":"51","author":"PJ O'Dwyer","year":"1991","unstructured":"O\u2019Dwyer PJ, LaCreta F, Nash S, Tinsley PW, Schilder R, Clapper ML, et al. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res. 1991;51:6059\u201365.","journal-title":"Cancer Res"},{"key":"348_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0167-4838(93)90245-M","volume":"1164","author":"S Awasthi","year":"1993","unstructured":"Awasthi S, Srivastava SK, Ahmad F, Ahmad H, Ansari GA. Interactions of glutathione S-transferase-pi with ethacrynic acid and its glutathione conjugate. Biochim Biophys Acta. 1993;1164:173\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"348_CR21","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1038\/onc.2008.90","volume":"27","author":"M Hassan","year":"2008","unstructured":"Hassan M, Alaoui A, Feyen O, Mirmohammadsadegh A, Essmann F, Tannapfel A, et al. The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways. Oncogene. 2008;27:4557\u201368.","journal-title":"Oncogene"},{"key":"348_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.trecan.2021.12.002","volume":"8","author":"NV Ivanisenko","year":"2022","unstructured":"Ivanisenko NV, Seyrek K, Hillert-Richter LK, Konig C, Espe J, Bose K, et al. Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks. Trends Cancer. 2022;8:190\u2013209.","journal-title":"Trends Cancer"},{"key":"348_CR23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1365-2141.2005.05378.x","volume":"128","author":"MB Valnet-Rabier","year":"2005","unstructured":"Valnet-Rabier MB, Challier B, Thiebault S, Angonin R, Margueritte G, Mougin C, et al. C-Flip protein expression in Burkitt\u2019s lymphomas is associated with a poor clinical outcome. Br J Haematol. 2005;128:767\u201373.","journal-title":"Br J Haematol"},{"key":"348_CR24","doi-asserted-by":"publisher","first-page":"111687","DOI":"10.1016\/j.ejmech.2019.111687","volume":"183","author":"M Hossain","year":"2019","unstructured":"Hossain M, Das U, Dimmock JR. Recent advances in \u03b1,\u03b2-unsaturated carbonyl compounds as mitochondrial toxins. Eur J Med Chem. 2019;183:111687.","journal-title":"Eur J Med Chem"},{"key":"348_CR25","doi-asserted-by":"publisher","first-page":"108187","DOI":"10.1016\/j.phrs.2026.108187","volume":"227","author":"R Roskoski Jr.","year":"2026","unstructured":"Roskoski R Jr. Bruton protein-tyrosine kinase (BTK) FDA-approved small molecule inhibitors used for the management of neoplastic and inflammatory disorders. Pharmacol Res. 2026;227:108187.","journal-title":"Pharmacol Res"}],"container-title":["Biological Procedures Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12575-026-00348-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-026-00348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-026-00348-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:27:38Z","timestamp":1790288858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12575-026-00348-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1186\/s12575-026-00348-y","relation":{},"ISSN":["1480-9222"],"issn-type":[{"value":"1480-9222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"13 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were approval by the Ethics Committee of Shenyang Pharmaceutical University. (Permit Number: YPU-IACUC-S2023-1129\u2013111).","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"36"}}